BRD-3308

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBRD-3308
Drug Alias NameBRD-3308
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 3 inhibitors
TargetsHistone deacetylase 3
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHarvard Medical School
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A